A PHASE 2B, RANDOMIZED, CONTROLLED TRIAL EVALUATING GS-5806 IN LUNG TRANSPLANT (LT) RECIPIENTS WITH RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Angel,Luis F.

Funded by

GILEAD SCIENCE

Research Start Date

01/01/2017

Status

Active

Clinical Care

Drug Discovery

Infectious Disease

Bioscience Research Panel